Global Clinical Trials Market 2021-2031 by Product Category (Drugs, Devices, Procedures), Phase (I, II, III, IV), Design (Interventional, Observational, Expanded Access), Service Type (Site Identification, Lab Services, Supply & Logistic, Decentralized Services), Indication (Oncology, Infectious Diseases, Cardiology, Obesity, Diabetes, Neurology), End User, and Region: Trend Forecast and Growth Opportunity
Global Clinical Trials market will reach $ 79,977.1 million by 2031, growing by 6.8% annually over 2021-2031, driven by the increasing number of clinical trials and increase in demand for novel therapies, rising prevalence on chronic diseases such as cancer and diabetes, the outbreak of tropical and infectious diseases such as COVID-19, and the increase in government initiatives and R&D investments.
Highlighted with 88 tables and 111 figures, this 198-page report “Global Clinical Trials Market 2021-2031 by Product Category (Drugs, Devices, Procedures), Phase (I, II, III, IV), Design (Interventional, Observational, Expanded Access), Service Type (Site Identification, Lab Services, Supply & Logistic, Decentralized Services), Indication (Oncology, Infectious Diseases, Cardiology, Obesity, Diabetes, Neurology), End User, and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global clinical trials market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global clinical trials market in every aspect of the classification from perspectives of Product Category, Phase, Design, Service Type, Indication, End User, and Region.
Based on Product Category, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Trials of Drugs
o Small Molecule Drugs
o Vaccines
o Cell & Gene Therapy
o Other Drugs
• Trials of Devices
• Trials of Procedures
Based on Phase, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Phase I
• Phase II
• Phase III
• Phase IV
By Design, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Interventional Studies
o Randomized Control Trial
o Adaptive Clinical Trial
o Non-randomized Control Trial
• Observational Studies
o Cohort Study
o Case Control Study
o Cross Sectional Study
o Ecological Study
• Expanded Access Trials
By Service Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Protocol Designing
• Site Identification
• Patient Recruitment
• Laboratory Services
• Bioanalytical Testing Services
• Clinical Trial Data Management Services
• Clinical Trial Supply & Logistic Services
• Decentralized Clinical Trial Services
• Medical Device Testing Services
• Other Clinical Trial Services
By Indication, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Oncology
• Infectious Diseases
• Cardiology
• Obesity
• Diabetes
• Neurology
• Immunology
• Pain Management
• Other Indications
By End User, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Pharmaceutical and Biotechnological Companies
• Clinical Research Organizations
• Clinical Testing Laboratories
• Other End Users
Geographically, the following regions together with the listed national/local markets are fully investigated:
• North America (U.S., Canada, and Mexico)
• Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
• APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
• South America (Brazil, Chile, Argentina, Rest of South America)
• MEA (UAE, Saudi Arabia, South Africa, Other Nations)
For each aforementioned region and country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of all regional markets by country and split of key national markets by Phase, Design, and Indication over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Accell Clinical Research LLC
Charles River Laboratory
ClinDatrix Inc
Clinipace
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
ICON PLC
IQVIA Holdings, Inc.
Laboratory Corporation of America
Novo Nordisk AS
PAREXEL International Corporation
Pfizer Inc.
Pharmaceutical Product Development LLC
PRA Health Sciences
Sanofi SA
SGS SA
Syneos Health Inc.
Wuxi AppTec Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
1 Introduction 10
1.1 Industry Definition and Research Scope 10
1.1.1 Industry Definition 10
1.1.2 Research Scope 11
1.2 Research Methodology 14
1.2.1 Overview of Market Research Methodology 14
1.2.2 Market Assumption 15
1.2.3 Secondary Data 15
1.2.4 Primary Data 15
1.2.5 Data Filtration and Model Design 16
1.2.6 Market Size/Share Estimation 17
1.2.7 Research Limitations 18
1.3 Executive Summary 19
2 Market Overview and Dynamics 22
2.1 Market Size and Forecast 22
2.1.1 Impact of COVID-19 on World Economy 24
2.1.2 Impact of COVID-19 on the Market 26
2.2 Major Growth Drivers 28
2.3 Market Restraints and Challenges 35
2.4 Emerging Opportunities and Market Trends 38
2.5 Porter’s Fiver Forces Analysis 42
3 Segmentation of Global Market by Product Category 46
3.1 Market Overview by Product Category 46
3.2 Trials of Drugs 48
3.2.1 Small Molecule Drugs 49
3.2.2 Vaccines 50
3.2.3 Cell & Gene Therapy 51
3.2.4 Other Drugs 52
3.3 Trials of Devices 53
3.4 Trials of Procedures 54
4 Segmentation of Global Market by Phase 55
4.1 Market Overview by Phase 55
4.2 Phase I 57
4.3 Phase II 58
4.4 Phase III 59
4.5 Phase IV 60
5 Segmentation of Global Market by Design 61
5.1 Market Overview by Design 61
5.2 Interventional Studies 63
5.2.1 Randomized Control Trial 65
5.2.2 Adaptive Clinical Trial 66
5.2.3 Non-randomized Control Trial 67
5.3 Observational Studies 68
5.3.1 Cohort Study 70
5.3.2 Case Control Study 71
5.3.3 Cross Sectional Study 72
5.3.4 Ecological Study 73
5.4 Expanded Access Trials 74
6 Segmentation of Global Market by Service Type 75
6.1 Market Overview by Service Type 75
6.2 Protocol Designing 77
6.3 Site Identification 78
6.4 Patient Recruitment 79
6.5 Laboratory Services 80
6.6 Bioanalytical Testing Services 81
6.7 Clinical Trial Data Management Services 82
6.8 Clinical Trial Supply & Logistic Services 83
6.9 Decentralized Clinical Trial Services 84
6.10 Medical Device Testing Services 85
6.11 Other Clinical Trial Services 86
7 Segmentation of Global Market by Indication 87
7.1 Market Overview by Indication 87
7.2 Oncology 89
7.3 Infectious Diseases 90
7.4 Cardiology 91
7.5 Obesity 92
7.6 Diabetes 93
7.7 Neurology 94
7.8 Immunology 95
7.9 Pain Management 96
7.10 Other Indications 97
8 Segmentation of Global Market by End User 98
8.1 Market Overview by End User 98
8.2 Pharmaceutical and Biotechnological Companies 100
8.3 Clinical Research Organizations 101
8.4 Clinical Testing Laboratories 102
8.5 Other End Users 103
9 Segmentation of Global Market by Region 104
9.1 Geographic Market Overview 2021-2031 104
9.2 North America Market 2021-2031 by Country 108
9.2.1 Overview of North America Market 108
9.2.2 U.S. 112
9.2.3 Canada 115
9.2.4 Mexico 117
9.3 European Market 2021-2031 by Country 119
9.3.1 Overview of European Market 119
9.3.2 Germany 123
9.3.3 U.K. 125
9.3.4 France 127
9.3.5 Spain 129
9.3.6 Italy 131
9.3.7 Russia 133
9.3.8 Rest of European Market 135
9.4 Asia-Pacific Market 2021-2031 by Country 137
9.4.1 Overview of Asia-Pacific Market 137
9.4.2 Japan 141
9.4.3 China 144
9.4.4 Australia 146
9.4.5 India 148
9.4.6 South Korea 150
9.4.7 Rest of APAC Region 152
9.5 South America Market 2021-2031 by Country 154
9.5.1 Argentina 157
9.5.2 Brazil 159
9.5.3 Chile 161
9.5.4 Rest of South America Market 163
9.6 MEA Market 2021-2031 by Country 164
9.6.1 UAE 167
9.6.2 Saudi Arabia 169
9.6.3 South Africa 171
9.6.4 Other National Markets 173
10 Competitive Landscape 174
10.1 Overview of Key Vendors 174
10.2 New Product Launch, Partnership, Investment, and M&A 178
10.3 Company Profiles 179
Accell Clinical Research LLC 179
Charles River Laboratory 181
ClinDatrix Inc 182
Clinipace 183
Eli Lilly and Company 184
F. Hoffmann-La Roche Ltd. 185
ICON PLC 186
IQVIA Holdings, Inc. 187
Laboratory Corporation of America 188
Novo Nordisk AS 189
PAREXEL International Corporation 190
Pfizer Inc. 191
Pharmaceutical Product Development LLC 192
PRA Health Sciences 193
Sanofi SA 194
SGS SA 195
Syneos Health Inc. 196
Wuxi AppTec Inc. 197
RELATED REPORTS 198